Ezrin-Radixin-Moesin-binding Sequence of PSGL-1 Glycoprotein Regulates Leukocyte Rolling on Selectins and Activation of Extracellular Signal-regulated Kinases-Reference-Cited by-同舟云学术

Ezrin-Radixin-Moesin-binding Sequence of PSGL-1 Glycoprotein Regulates Leukocyte Rolling on Selectins and Activation of Extracellular Signal-regulated Kinases

Published:2012-03 Issue:13 Volume:287 Page:10693-10702
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Spertini Caroline,Baïsse Bénédicte,Spertini Olivier

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference42 articles.

1. Getting to the site of inflammation. The leukocyte adhesion cascade updated;Ley;Nat. Rev. Immunol.,2007

2. P-selectin glycoprotein ligand 1 is a ligand for L-selectin on neutrophils, monocytes, and CD34+ hematopoietic progenitor cells;Spertini;J. Cell Biol.,1996

3. Sequential contribution of L- and P-selectin to leukocyte rolling in vivo;Ley;J. Exp. Med.,1995

4. Neutrophil-neutrophil interactions under hydrodynamic shear stress involve L-selectin and PSGL-1. A mechanism that amplifies initial leukocyte accumulation of P-selectin in vitro;Walcheck;J. Clin. Invest.,1996

5. Differential requirements for core2 glucosaminyltransferase for endothelial L-selectin ligand function in vivo;Sperandio;J. Immunol.,2001

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of P-selectin/PSGL-1 in regulating NETs as a novel mechanism in cerebral ischemic injury;Frontiers in Neurology;2024-07-03

2. Correlation between plasma PSGL‐1 and FIGO stage, tumor metastasis, and survival in epithelial ovarian cancer;Biotechnology and Applied Biochemistry;2024-03-17

3. Ezrin's role in gastric cancer progression: Implications for immune microenvironment modulation and therapeutic potential;Heliyon;2024-03

4. Circadian Regulator CLOCK Drives Immunosuppression in Glioblastoma;Cancer Immunology Research;2022-04-12

5. Targeting the PSGL-1 Immune Checkpoint Promotes Immunity to PD-1–Resistant Melanoma;Cancer Immunology Research;2022-03-18